SCNI

SCINAI IMMUNOTHERAPEUTICS LT

SCNI·09073Q204·UQ·ADR·Healthcare - Biotechnology-13D/G

SCNI (SCINAI IMMUNOTHERAPEUTICS LT) is held by 9 institutional investors as of Q2 2026. Largest holders: CITADEL ADVISORS LLC ($15,726), Virtu Financial LLC ($5,000), XTX Topco Ltd ($4,235). Net institutional sentiment: Bullish.

9
Holders
(1 Elite)
$35,434
Total Value
88% (8)
Consensus
7 buying - 1 selling
13F: Insider & Congress: Updated regularly
SCNI

Smart Money Verdict

View all
Loading verdict
Held by 9 funds
1 elite

Who's Trading

Source dates: Price Oct 13, 2026 · Insiders Jun 18, 2026 · Activists Jul 9, 2026 · Congress none

ActivistLJLCK JNK 1 LLC6.3%Jul 9, 2026
ActivistSDSTONE DANIEL E.9.9%Jul 1, 2026
InsiderRAReichman AmirVest 400.0M shJun 16, 2026
Checking access…

Top Holders

Checking access…
Action
New
62,257$15,7260.0%-54.15%
28
New
19,485$5,0000.0%-54.15%
21
Decreased
16,764(-30.3%)$4,2350.0%-83.71%
0
Increased
13,513(+619.5%)$3,4170.0%-79.84%
15
New
12,035$3,0400.0%-54.15%
20
New
12,088$3,0000.0%-54.15%
20
Increased
3,955(+330.4%)$1,0010.0%-68.00%
12
Unchanged
58$150.0%-95.83%
0
New
815$00.0%-54.15%
17
SCNISCNISCINAI IMMUNOTHERAPEUTICS LT

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used